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Abstract
Taurine, a sulfur-containing b-amino acid, is highly contained in heart and skeletal muscle. Taurine has a variety of
biological actions, such as ion movement, calcium handling and cytoprotection in the cardiac and skeletal muscles.
Meanwhile, taurine deficiency leads various pathologies, including dilated cardiomyopathy, in cat and fox. However,
the essential role of taurine depletion on pathogenesis has not been fully clarified. To address the physiological
role of taurine in mammalian tissues, taurine transporter-(TauT-) knockout models were recently generated. TauTKO
mice exhibited loss of body weight, abnormal cardiac function and the reduced exercise capacity with tissue taur-
ine depletion. In this chapter, we summarize pathological profile and histological feature of heart and skeletal mus-
cle in TauTKO mice.
Background
Taurine is a most abundant free amino acid in mamma-
lian tissues with an intracellular concentration of 5-20
µmol/g wet weight [1,2]. A number of evidences
revealed that taurine is a cytoprotective agent. Supple-
mentation of taurine is effective to a variety of disorders,
such as cardiovascular diseases, skeletal muscle disor-
ders, etc. Meanwhile, taurine deficiency related to some
kinds of pathophysiological conditions in cats and foxes,
such as dilated cardiomyopathy, retinal degradation and
reproduction[3-5].
Taurine transporter (TauT; SLC6a6) is a sodium and
chloride ion-dependent transporter, and is expressed
ubiquitously in mammalian tissues [6]. Since the capa-
city to synthesize taurine inm o s tt i s s u e s ,s u c ha sh e a r t
and skeletal muscle, is limited, maintenance of the large
intracellular taurine pool may depend upon uptake of
the amino acid from extracellular space via TauT. This
transport process requires the accumulation of taurine
against a substantial concentration gradient, as the
concentration of taurine is 100 fold less in the plasma
(20-100 µM) than in the tissues.
Recently, transgenic mice lacking TauT gene have
been generated by two groups [7,8]. A variety of disor-
ders has been reported in various tissues, such as eye,
kidney, heart, muscle, etc., accompanied with drastic
taurine deficiency in TauTKO mice [7-10]. In this chap-
ter, we report the phenotype of TauTKO mice and dis-
cuss the role of taurine deficiency in hearts and skeletal
muscles.
Analysis of taurine transporter knockout mice
In our TauTKO mice, targeting construct for generation
of transgenic mice was designed to replace exons 2–4o f
the TauT gene with a cassette containing neomycin-
resistance gene [7]. While a truncated TauT mRNA
lacking exon 2-4 was detected in TauTKO tissues, taur-
ine influx was eliminated in the cells isolated from
TauTKO mice, indicating loss of taurine transport activ-
ity in TauTKO mice. Tissue taurine level is severely
decreased in several tissues. Especially, cardiac taurine
could not be detected in TauTKO mice, and skeletal
muscle taurine level is decreased by 96% in TauTKO
mice compared with wild-type mice. Similarly, in
another TauTKO mouse model which was reported by
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and taurine level in skeletal and cardiac muscles
was decreased by about 98%, while taurine level in
brain, kidney and liver is decreased by 70-90 % com-
pared to wild-type mice [8]. These data illustrate that
maintenance of intracellular taurine pool in cardiac and
skeletal muscle is extremely dependent upon taurine
transport activity.
TauTKO mice exhibited a lower body weight than
their control littermates. Furthermore, knocking out
TauT causes a decrease in tissue weight, such as heart,
skeletal muscle, brain etc [7,8]. Food and water intake
were identical in the TauTKO and control mice.
Cardiac Phenotype of TauTKO mice
Oral supplementation of taurine is effective to animals
and human patients with congestive heart failure and
cardiomyopathy [11,12], indicating that taurine would
play an important role in cardiac homeostasis and cardi-
oprotection against pathological stress. It has been
reported that taurine-deficient diet impaired cardiac
function and led to dilated cardiomyopathy in cat and
fox, which have very low capacity of taurine synthesis
[3,13]. Furthermore, drug-induced taurine deficiency by
the inhibition of taurine uptake using guanidinoethane
sulfonate (GES) or b-alanine led to some cardiac defects
in mice or rats [11,14].
In TauTKO model, we determined the cardiac func-
tion of TauTKO mice. Echocardiographic analysis
revealed that fractional shortening was diminished in
the old (>9-month-old) TauTKO mice, whereas we
failed to detect a functional difference between the
young (5-month-old) wild-type mice and KO mice
(Table 1) [7]. Detailed functional analysis on Langen-
dorff perfused heart also demonstrated the age-depen-
dent cardiac dysfunction in TauTKO mice (Unpublished
data).
It is well established that the expression of fetal genes,
including atrial natriuretic peptide (ANP), brain
natriuretic peptide (BNP) and b-myosin heavy chain
(bMHC), is reactivated in a variety of cardiac pathologi-
cal conditions, such as ischemia, heart failure, hypertro-
phy and atrophy [15]. These cardiac failure markers
were significantly elevated in both young and old
TauTKO mice (Fig. 1) [7]. Consistent with the cardiac
function, the inductions of these genes were more sig-
nificant in the old TauTKO mice. These data indicate
that knockout of the TauT gene leads to an age-depen-
dent dilated cardiomyopathy.
On the other hand, Warskulat et al. reported that
TauTKO mice exhibited normal cardiac function [9].
These inconsistent results between two TauTKO models
m a yb ed u et ot h ed i f f e r e n c eo fg e n e t i cb a c k g r o u n d ,
since the difference of inbred strains affects the cardio-
vascular phenotypes and susceptibilities against patholo-
gical stressors in mice [16]. We used mice which
backcrossed at least 4 times into C57BL/6 line to mini-
mize genetic differences, while Warskulat et al. reported
the use of F2 mixed C57BL/6 amd 129/SvJ strains.
Meanwhile, Warskulat et al. also reported that biomar-
ker genes for heart failure, including ANP, BNP and
CARP, are upregulated in TauTKO hearts consistent
with our TauTKO model [17]. Furthermore, they also
demonstrated that the TauTKO hearts showed a switch
from alpha-actin 1 (skeletal muscle type) to alpha-actin
2 (smooth muscle type) expression [17]. These data sug-
gest that other TauTKO mice (Warskulat et al) may
have the aptitude toward heart failure, and hearts may
be more susceptible to exogenous stresses in TauTKO
mice.
Histological analysis revealed that TauTKO mice
undergo ventricular remodeling, characterized by dilated
ventricles and reductions in ventricular wall thickness
[7]. Furthermore, cross sectional area of ventricular car-
diomyocytes was decreased in TauTKO hearts, implying
the importance of taurine for cell size. Surprisingly, car-
diac fibrosis was not observed in TauTKO heart. Transi-
tion electron microscopic analysis demonstrated that
TauTKO hearts exhibited significant ultrastructural
damage of myofilament and mitochondria. Furthermore,
another important feature of TauTKO mice is the pre-
sence of autophagosome containing mitochondria.
Autophagy is a biological process, in which cells degrade
and recycle intracellular macromolecules and organelles.
It is considered to represent a cellular adaptation to
ensure survival, as injured and potentially damaging
organelles are targeted for elimination. There are several
triggers of mitochondrial autophagy, such as mtDNA
damage, lipid peroxidation and the mitochondrial per-
meability transition [18-20]. Thus, the triggers them-
selves might provide useful information on the
pathology that is occurring in the taurine knockout
heart.
Phenotype of exercise capacity and skeletal
muscle
Taurine is well known to modulate ion movement and
p l a yar o l ei nt h ee x c i t a t i on-contraction coupling
Table 1 Echocardiographic analysis of young and old
TauTKO mice
Young (5-month-old) Old (>9-month-old)
Genotype WT (n=3) TauTKO (n=4) WT (n=5) TauTKO (n=7)
LVIDd (cm) 0.37±0.03 0.35±0.03 0.41±0.01 0.40±0.01
LVIDs (cm) 0.25±0.04 0.26±0.02 0.27±0.01 0.31±0.01
FS (%) 30.87±9.22 25.65±4.75 34.18±2.52 22.48±1.92*
LVIDd; left ventricular end-diastolic internal dimension, LVIDs; left ventricular
end-systolic internal dimension, FS; fractional shortening, *; p<0.01 v.s. WT.
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reported that supplementation of taurine improved exer-
cise capacity in rats and attenuated the exercise-induced
oxidative injury [23,24]. However, the effect of taurine
deficiency on the exercise has been unclear. It has been
reported that supplementation of GES to decrease in
taurine content in muscles reduced force output and
increased the endurance of skeletal muscles in rats [25].
However, since GES itself directly increases susceptibil-
ity to Ca
2+ on isolated muscle skinned fiber, the phar-
macological action of GES must influence to the
experiments using taurine depleted animal models [26].
In TauTKO mice, weight-loaded swimming test
revealed that exercise endurance time was severely
reduced compared to wild-type mice (118 ± 2.3 min in
wild-type vs 10 ±2.5 min in TauTKO, p<0.01) [7]. Addi-
tionally, forced treadmill test on uphill road also
revealed that the duration of running time to exhaustion
is reduced in TauTKO mice (49.0±11.0 min in wild-type
vs 14.8±9.2 min in TauTKO, p<0.01). Warskulat et al.
have also reported that total running distance to exhaus-
tion on the treadmill is reduced by more than 80% in
TauTKO mice [9]. These data indicate that taurine defi-
ciency may reduce muscle function in skeletal muscles.
Moreover, Warskulat et al. demonstrated that X-ray stu-
dies of the skeleton did not reveal morphological disor-
ders in TauTKO mice, indicating that skeletal muscle
abnormalities may be associated with the reduction of
exercise capacity in TauTKO mice.
S i n c eT a u T K Om i c el o s tm u s c l em a s s ,t h es k e l e t a l
muscle was analyzed histologically [7]. As expected for
atrophic muscle, the myofibrillar cross sectional area of
the tibial anterior muscle of the mutant mice was
remarkably reduced compared to that of their littermate
Figure 1 Age-dependent induction of heart failure markers in TauTKO mice Northern blot analyses of mRNA from wild-type (WT) and
TauTKO (KO) hearts revealed the increased expression of mRNA for brain natriuretic peptide (BNP) and b-myosin heavy chain (bMHC) in TauTKO
mice. GAPDH mRNA was measured to internal control.
Figure 2 Histological disorders in skeletal muscle of TauTKO mice. A) Representative micrographs of tibial anterior muscle sections of
TauTKO mice. The arrow indicates a necrotic cell. B) Representative electron micrographs of tibial anterior muscle sections of TauTKO mice.
Magnification; ×3000. The arrowheads indicate myofilament fragmentations.
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TauTKO muscles (Fig. 2A), indicating that taurine may
play a role in the regulation of cell volume and cell sur-
vival in skeletal muscle cells. Electron microscopy
revealed some kinds of ultrastructural abnormalities in
TauTKO muscle, such as filament fragmentation, mem-
branous cytoplasmic body and lipid droplet (Fig. 2B).
These observations suggest that taurine depletion may
result in destabilization of myofilament and other cyto-
solic organelle in skeletal muscle. Clearly, further studies
are required to clarify the mechanism underlying taurine
depletion-induced muscle disorders.
Conclusion
TauTKO mice displayed the dilated cardiomyopathy,
consistent with the phenotype of taurine-depleted cats.
These data illustrate that taurine depletion is an inde-
pendent etiology of cardiomyopathy. This model will
provide benefits to find the molecular mechanism
underlying taurine-depleted cardiomyopathy. Further-
more, lacking TauT results in aging-dependent cardiac
dysfunction, indicating that taurine deficient hearts
might be less able to tolerate aging. Aging-dependent
disorders have been reported in several tissues of
TauTKO mice, including visual, auditory, olfactory and
renal dysfunctions and hepatitis [10,27,28]. Taurine defi-
ciency i likely to increase susceptibility against stress,
such as oxidative stress, which in turn causes to acceler-
ated aging.
Acknowledgements
This study was supported in part by a Grants-in-Aid from the Ministry of
Health, Labor and Welfare and from the Ministry of Education, Science,
Sports and Culture of Japan. This study was also partly granted by Taisho
Pharmaceutical Ltd.
This article has been published as part as part of Journal of Biomedical
Science Volume 17 Supplement 1, 2010: Proceedings of the 17th
International Meeting of Taurine. The full contents of the supplement are
available online at http://www.jbiomedsci.com/supplements/17/S1.
Author details
1Department of Pharmacy, School of Pharmacy, Hyogo University of Health
Sciences, Kobe, Japan.
2Department of Clinical Pharmacology and
Pharmacogenomics, Graduate School of Pharmaceutical Sciences, Osaka
University, Osaka, Japan.
3Department of Pharmacology, College of Medicine,
University of South Alabama, Mobile, AL, USA.
Competing interests
The authors declare that they have no competing interests.
Published: 24 August 2010
References
1. Chapman RA, Suleiman MS, Earm YE: Taurine and the heart. Cardiovasc Res
1993, 27:358-63.
2. Chesney RW: Taurine: its biological role and clinical implications. Adv
Pediatr 1985, 32:1-42.
3. Pion PD, Kittleson MD, Rogers QR, Morris JG: Myocardial failure in cats
associated with low plasma taurine: a reversible cardiomyopathy. Science
1987, 237:764-8.
4. Hayes KC, Carey RE, Schmidt SY: Retinal degeneration associated with
taurine deficiency in the cat. Science 1975, 188:949-51.
5. Sturman JA: Dietary taurine and feline reproduction and development. J
Nutr 1991, 121:S166-70.
6. Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, Handler JS:
Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl
(-)-dependent taurine transporter that is regulated by hypertonicity. Proc
Natl Acad Sci U S A 1992, 89:8230-4.
7. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K,
Yoshiyama M, Ikawa M, Okabe M, et al: Taurine depletion caused by
knocking out the taurine transporter gene leads to cardiomyopathy
with cardiac atrophy. J Mol Cell Cardiol 2008, 44:927-37.
8. Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW,
Warskulat U, Haussinger D: Disruption of the taurine transporter gene
(taut) leads to retinal degeneration in mice. Faseb J 2002, 16:231-3.
9. Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW,
Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D: Taurine transporter
knockout depletes muscle taurine levels and results in severe skeletal
muscle impairment but leaves cardiac function uncompromised. Faseb J
2004, 18:577-9.
10. Warskulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F,
Haussinger D: Phenotype of the taurine transporter knockout mouse.
Methods Enzymol 2007, 428:439-58.
11. Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A,
Tanaka Y, Kishimoto S, Sperelakis N: Beneficial effect of taurine in rabbits
with chronic congestive heart failure. Am Heart J 1986, 112:1278-84.
12. Azuma J, Hasegawa H, Sawamura A, Awata N, Ogura K, Harada H,
Yamamura Y, Kishimoto S: Therapy of congestive heart failure with orally
administered taurine. Clin Ther 1983, 5:398-408.
13. Moise NS, Pacioretty LM, Kallfelz FA, Stipanuk MH, King JM, Gilmour RF Jr.:
Dietary taurine deficiency and dilated cardiomyopathy in the fox. Am
Heart J 1991, 121:541-7.
14. Lake N: Loss of cardiac myofibrils: mechanism of contractile deficits
induced by taurine deficiency. Am J Physiol 1993, 264:H1323-6.
15. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H: Return to the fetal gene
program protects the stressed heart: a strong hypothesis. Heart Fail Rev
2007, 12:331-43.
16. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW: Cardiac
response to pressure overload in 129S1/SvImJ and C57BL/6J mice:
temporal- and background-dependent development of concentric left
ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2007, 292:H2119-30.
17. Warskulat U, Andree B, Lusebrink J, Kohrer K, Haussinger D: Switch from
actin alpha1 to alpha2 expression and upregulation of biomarkers for
pressure overload and cardiac hypertrophy in taurine-deficient mouse
heart. Biol Chem 2006, 387:1449-54.
18. Scherz-Shouval R, Elazar Z: ROS, mitochondria and the regulation of
autophagy. Trends Cell Biol 2007, 17:422-7.
19. Rodriguez-Enriquez S, He L, Lemasters JJ: Role of mitochondrial
permeability transition pores in mitochondrial autophagy. Int J Biochem
Cell Biol 2004, 36:2463-72.
20. Dirks AJ, Hofer T, Marzetti E, Pahor M, Leeuwenburgh C: Mitochondrial
DNA mutations, energy metabolism and apoptosis in aging muscle.
Ageing Res Rev 2006, 5(z):179-95.
21. Conte Camerino D, Tricarico D, Pierno S, Desaphy JF, Liantonio A, Pusch M,
Burdi R, Camerino C, Fraysse B, De Luca A: Taurine and skeletal muscle
disorders. Neurochem Res 2004, 29:135-42.
22. De Luca A, Pierno S, Tricarico D, Desaphy JF, Liantonio A, Barbieri M,
Camerino C, Montanari L, Camerino DC: Taurine and skeletal muscle ion
channels. Adv Exp Med Biol 2000, 483:45-56.
23. Yatabe Y, Miyakawa S, Ohmori H, Mishima H, Adachi T: Effects of taurine
administration on exercise. Adv Exp Med Biol 2009, 643:245-52.
24. Dawson R Jr., Biasetti M, Messina S, Dominy J: The cytoprotective role of
taurine in exercise-induced muscle injury. Amino Acids 2002, 22:309-24.
25. Hamilton EJ, Berg HM, Easton CJ, Bakker AJ: The effect of taurine
depletion on the contractile properties and fatigue in fast-twitch skeletal
muscle of the mouse. Amino Acids 2006, 31:273-8.
26. Cuisinier C, Gailly P, Francaux M, Lebacq J: Effects of guandinoethane
sulfonate on contraction of skeletal muscle. Adv Exp Med Biol 2000,
483:403-9.
27. Huang DY, Boini KM, Lang PA, Grahammer F, Duszenko M, Heller-Stilb B,
Warskulat U, Haussinger D, Lang F, Vallon V: Impaired ability to increase
Ito et al. Journal of Biomedical Science 2010, 17(Suppl 1):S20
http://www.jbiomedsci.com/content/17/S1/S20
Page 4 of 5water excretion in mice lacking the taurine transporter gene TAUT.
Pflugers Arch 2006, 451:668-77.
28. Warskulat U, Borsch E, Reinehr R, Heller-Stilb B, Monnighoff I, Buchczyk D,
Donner M, Flogel U, Kappert G, Soboll S, et al: Chronic liver disease is
triggered by taurine transporter knockout in the mouse. Faseb J 2006,
20:574-6.
doi:10.1186/1423-0127-17-S1-S20
Cite this article as: Ito et al.: Cardiac and skeletal muscle abnormality in
taurine transporter-knockout mice. Journal of Biomedical Science 2010 17
(Suppl 1):S20.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ito et al. Journal of Biomedical Science 2010, 17(Suppl 1):S20
http://www.jbiomedsci.com/content/17/S1/S20
Page 5 of 5